Table 1.
Cases | Injected | Failed | Survival for 12–14 days | Survival for 15–30 days | Survival for 31 days or longer |
---|---|---|---|---|---|
EMB-85 | 3 | 1 | 1 | 1 | |
EMB-68 | 4 | 3 | 1 | ||
EMB-79 | 6 | 5 | 1 | ||
EMB-103 | 4 | 2 | 1 | 1 | |
EMB-102 | 7 | 6 | 1 | ||
EMB-100 | 6 | 5 | 1 | ||
EMB-94 | 3 | 1 | 2 | ||
EMB-87 | 4 | 3 | 1 | ||
EMB-77 | 5 | 3 | 2 | ||
EMB-74 | 5 | 3 | 2 | ||
EMB-73 | 6 | 3 | 3 | ||
EMB-69 | 5 | 5 | |||
EMB-64 | 5 | 4 | 1 | ||
EMB-41 | 7 | 6 | 1 | ||
EMB-180 | 7 | 6 | 1 | ||
Total | 77 | 56 | 4 | 11 | 6 |
Rate of success (all) | 27.3% | ||||
Rate of success (graft survival for 15 days or longer) | 22.1% | ||||
Rate of success (graft survival for 31 days or longer) | 7.8% |